quinazolines has been researched along with pd 180970 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Corbin, AS; Deininger, MW; Druker, BJ; Griswold, IJ; Heinrich, MC; La Rosée, P; Reimer, CL; Yee, KW | 1 |
| Erdmann, F; Platzer, C; Rohe, A; Schmidt, M; Sippl, W; Slynko, I; Wichapong, K | 1 |
2 other study(ies) available for quinazolines and pd 180970
| Article | Year |
|---|---|
Sensitivity of oncogenic KIT mutants to the kinase inhibitors MLN518 and PD180970.
Topics: Animals; Cell Line; Cell Proliferation; Humans; Leukemia, Myeloid, Acute; Mastocytosis, Systemic; Mice; Mutation, Missense; Piperazines; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-kit; Pyridones; Pyrimidines; Quinazolines | 2004 |
Application of docking and QM/MM-GBSA rescoring to screen for novel Myt1 kinase inhibitors.
Topics: Aza Compounds; Benzodioxoles; Drug Design; Humans; Ligands; Membrane Proteins; Molecular Docking Simulation; Morpholines; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Pyridones; Pyrimidines; Quinazolines | 2014 |